Sonoma Pharmaceuticals (SNOA) announced that Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society Seal of Acceptance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNOA:
- Sonoma Pharmaceuticals reports Q2 EPS (32c) vs. (59c) last year
- Sonoma Pharmaceuticals, Medline launch HOCI wound cleanser
- Sonoma Pharmaceuticals lists facial spray under FDA’s MoCRA
- Sonoma Pharmaceuticals Highlights Growth in Healthcare Sector
- Sonoma Pharmaceuticals Enters Sales Agreement with Ladenburg